Patent · US Active

Anti-VEGF antibodies

US7691977B2 · kind B2 · utility

67Cited by
21References
13Claims
0Family size

Assignee

Inventors

Key dates

Filing dateOct 19, 2006
Grant dateApr 6, 2010
Priority date
Expiry dateOct 19, 2026

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2317/92
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Anti-VEGF antibodies and variants thereof, including those having high affinity for binding to VEGF, are disclosed. Also provided are methods of using phage display technology with naïve libraries to generate and select the anti-VEGF antibodies with desired binding and other biological activities. Further contemplated are uses of the antibodies in research, diagnostic and therapeutic applications.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.